Kangmei Pharma | 600518 - Assets

Stock Price
1.90
Daily Change
-0.01 -0.52%
Monthly
-2.06%
Yearly
-16.30%
Q1 Forecast
1.86

Kangmei Pharma reported CNY13.68B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 58.13M 21.58M Jun/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Genomma Lab Internacional MXN 23.61B 636.15M Sep/2025
Hypermarcas BRL 25.15B 916.05M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
IQVIA Holdings USD 28.73B 95M Sep/2025
Jiangsu Hengrui CNY 68.33B 5.43B Sep/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Moderna USD 12.14B 125M Sep/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.14B 223.84M Sep/2025
Sh Fosun Pharma CNY 118.12B 707.2M Sep/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Viatris USD 37.92B 491.1M Sep/2025
Wuxi Apptec CNY 94.61B 10.78B Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025